Get access to our best features

Pfizer seeks to expand omicron booster to 5- to 11-year-olds

Summary by Ground News
Pfizer Inc and its German partner BioNTech on Monday sought the U.S. Food and Drug Administration's authorization for an Omicron-tailored COVID-19 vaccine booster for children aged 5 through 11 years. The application comes just days after Moderna also applied for FDA authorization of its own Omicron-targeting shot in adolescents aged 12 to 17 years and children aged six to 11.
2 months ago·Washington, United States

News Articles

More Filters
All
Left
Center
Right

Pfizer/BioNTech seek FDA nod for new COVID boosters for children

The applications represent a step towards getting children vaccinated by a so-called bivalent vaccine, which targets both the original strain of the v..

2 months ago·Mumbai, India
Read Full Article

Pfizer/BioNTech seek FDA nod for new COVID boosters for children

Pfizer Inc and its German partner BioNTech on Monday sought the U.S. Food and Drug Administration's authorization for an Omicron-tailored COVID-19 vaccine booster for children aged 5 through 11 years.

2 months ago·United Kingdom
Read Full Article

Pfizer-BioNTech asks FDA to authorize new omicron-targeting COVID booster for children 5 to 11

Pfizer-BioNTech submitted an application for the FDA to authorize its BA.4/BA.5 bivalent COVID-19 vaccine for kids 5 to 11 at a 10-microgram dose.

2 months ago·United States
Read Full Article

Pfizer seeks to expand omicron booster to 5- to 11-year-olds

Pfizer asked U.S. regulators Monday to expand use of its updated COVID-19 booster shot to children ages 5 to 11.

2 months ago·United States
Read Full Article

Pfizer seeks to expand omicron booster to 5- to 11-year-olds

Pfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11

2 months ago·United States
Read Full Article

Pfizer asks FDA to authorize omicron Covid booster shots for kids ages 5 to 11

Pfizer's application to the FDA comes before clinical trial results of the omicron BA.5 booster shots have been published.

2 months ago·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

77% of the sources are Center
USA Today
Associated Press News
abc News
Star Advertiser
Bangor Daily News
Koco News5
+5
Reuters
CNBC
Pioneer Press
KCRA 3
Click on Detroit
WPLG
+45
Times of India
The Billings Gazette
Pittsburgh Tribune-Review
The National Desk
The National Herald
L 16%
C 76%
 
See less detail